Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Tomasz, Marjański"'
Publikováno v:
Current Oncology, Vol 31, Iss 7, Pp 3985-3993 (2024)
Background: The prediction of postoperative functional status in non-small cell lung cancer patients based on preoperative assessment of physical and respiratory capacity is inadequate based on recent RCTs. Material and methods: Prospectively collect
Externí odkaz:
https://doaj.org/article/0c251974a0c441fc9fb01cf99b32f836
Autor:
Witold Rzyman, Małgorzata Łazar-Poniatowska, Robert Dziedzic, Tomasz Marjański, Mariusz Łapiński, Rafał Dziadziuszko
Publikováno v:
Current Oncology, Vol 30, Iss 5, Pp 4551-4562 (2023)
Objectives: Treatment of superior sulcus tumors (SST) using concurrent chemoradiation followed by surgery is a current standard. However, due to the rarity of this entity, clinical experience in its treatment remains scarce. Here, we present the resu
Externí odkaz:
https://doaj.org/article/10fa31ad8ba44a279d2749fcc6d78148
Autor:
Ines Papak, Elżbieta Chruściel, Katarzyna Dziubek, Małgorzata Kurkowiak, Zuzanna Urban-Wójciuk, Tomasz Marjański, Witold Rzyman, Natalia Marek-Trzonkowska
Publikováno v:
International journal of molecular sciences. 23(13)
Natural killer cells are innate lymphocytes with the ability to lyse tumour cells depending on the balance of their activating and inhibiting receptors. Growing numbers of clinical trials show promising results of NK cell-based immunotherapies. Unlik
Autor:
Katarzyna Dziadziuszko, Małgorzata Jelitto-Górska, Robert Dziedzic, Marcin Ostrowski, Tomasz Marjański, Edyta Szurowska, Witold Rzyman, Rafal Dziadziuszko
Publikováno v:
Interactive CardioVascular and Thoracic Surgery. 29:266-274
OBJECTIVES The European Society of Thoracic Surgeons’ recommendations confirm the implementation of lung cancer screening in Europe. We compared 2 screening programmes, the Pilot Pomeranian Lung Cancer Screening Programme (pilot study) and the Molt
Autor:
Tomasz Marjański, Marcin Ostrowski, Robert Dziedzic, Witold Rzyman, Damian Wnuk, Wioletta Sawicka
Publikováno v:
Journal of Clinical Medicine, Vol 10, Iss 1686, p 1686 (2021)
Journal of Clinical Medicine
Volume 10
Issue 8
Journal of Clinical Medicine
Volume 10
Issue 8
The 6-min walk test (6MWT) is a simple method of identifying patients with a high risk of postoperative complications. In this study, we internally validated the previously obtained threshold value of 500 m in the 6MWT as differentiating populations
Autor:
Tomasz Marjański, Franciszek Binczyk, Marcin Ostrowski, Robert Dziedzic, Sylwia Pisiak, Sylwia Małgorzewicz, Mariusz Adamek, Joanna Polanska, Witold Rzyman
Publikováno v:
Transl Lung Cancer Res
BACKGROUND: Optimal selection criteria for the lung cancer screening programme remain a matter of an open debate. We performed a validation study of the three most promising lung cancer risk prediction models in a large lung cancer screening cohort o
Publikováno v:
Transl Lung Cancer Res
The diagnosis and treatment of early-stage lung cancer remains a clinical challenge. The broadening implementation of lung cancer screening has resulted in positive findings in numerous patients that are mostly non-malignant. Many other patients have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc2bc1d4c94bc156f723da414b15f7bd
https://europepmc.org/articles/PMC7947400/
https://europepmc.org/articles/PMC7947400/
Autor:
Witold Rzyman, Tomasz Marjański, Sofie Josefsson, Danush Davoodi, Wioletta Sawicka, Robert Dziedzic
Publikováno v:
J Thorac Dis
BACKGROUND: The incidence of lung cancer in the population of patients younger than 50 years of age is relatively low. The aim of this study was to compare the clinical outcomes of patients with early lung cancer onset (ELCO, onset before the age of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d7de47e806950fabbe5b35f66a0a570
https://europepmc.org/articles/PMC7330294/
https://europepmc.org/articles/PMC7330294/
Autor:
Natalia Marek-Trzonkowska, Wojciech Biernat, Carla Montesano, Witold Rzyman, Jacek Kowalski, Tomasz Marjański, Mateusz Gliwiński, Rafal Dziadziuszko, Roberta Bernardini, Łukasz Arcimowicz, Małgorzata Kurkowiak, Elżbieta Chruściel, Zuzanna Urban-Wójciuk
Publikováno v:
Cancers, Vol 12, Iss 3, p 683 (2020)
Cancers
Cancers
In recent years, much research has been focused on the field of adoptive cell therapies (ACT) that use native or genetically modified T cells as therapeutic tools. Immunotherapy with T cells expressing chimeric antigen receptors (CARs) demonstrated g
Publikováno v:
Advances in Medical Sciences. 63:230-236
Lung cancer causes an estimated 1.6 million deaths each year, being the leading cause of cancer-related deaths in the world. Late diagnosis and, in some cases, the high aggressiveness of the tumour result in low overall five-year survival rates of 12